Time Series Methods to Assess the Impact of Regulatory Action: A Study of UK Primary Care and Hospital Data on the Use of Fluoroquinolones.
Guo Y. et al, (2024), Pharmacoepidemiol drug saf, 33
Longitudinal trajectories of frailty are associated with short-term mortality in older people: A joint latent class models analysis using two UK primary care databases
Elhussein L. et al, (2024), Journal of clinical epidemiology, 111442 - 111442
Incidence and Complications of Rectopexy in the United Kingdom and United States, 2013-2022
Corby G. et al, (2024), Pharmacoepidemiology and drug safety, 33, 395 - 395
Natural History of Dermatomyositis and Polymyositis in Adults and Paediatric Populations: A Network Cohort Study Part of DARWIN EU®
Lopez-Guell K. et al, (2024), Pharmacoepidemiology and drug safety, 33, 326 - 326
Prevalence of Dermatomyositis and Polymyositis in Adults and Paediatric Populations: A Network Cohort Study Part of DARWIN EU®
Prats-Uribe A. et al, (2024), Pharmacoepidemiology and drug safety, 33, 156 - 157
Use of Systemic Fluoroquinolones in Primary Care and Hospital Settings in the UK: A Population-Level Cohort Study
Elhussein L. et al, (2024), Pharmacoepidemiology and drug safety, 33, 283 - 283
PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non-muscle-invasive bladder cancer.
Woodcock VK. et al, (2023), Bjui compass, 4, 322 - 330
Redefining polypharmacy in older people taking into account longitudinality: A joint latent class analysis
Elhussein LME. et al, (2023), Pharmacoepidemiology and drug safety, 32, 466 - 466
Estimating the Incidence and Key Risk Factors of Cardiovascular Disease in Patients at High Risk of Imminent Fracture Using Routinely Collected Real-World Data From the UK.
Pineda-Moncusí M. et al, (2022), J bone miner res, 37, 1986 - 1996
Longitudinal progression of frailty in older population and risk of mortality: An application of joint latent class models
Elhussein LME. et al, (2022), Pharmacoepidemiology and drug safety, 31, 300 - 300
Predicting Imminent Fractures in Patients With a Recent Fracture or Starting Oral Bisphosphonate Therapy: Development and International Validation of Prognostic Models.
Khalid S. et al, (2021), J bone miner res, 36, 2162 - 2176